Romain Neugebauer to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Romain Neugebauer has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.236
-
Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV. J Acquir Immune Defic Syndr. 2024 Aug; 96(4):393-398.
Score: 0.236